β-Blockers for Autism- < em > Help < /em > or < em > Hindrance < /em > ?

Psychopharmacol Bull. 2023 Dec 4;53(4):57-59.ABSTRACTA renewed interest in the use of β-blockers for neurodevelopmental disorders has recently resurfaced, notably as an addition to the limited psychopharmacological armamentarium of autism spectrum disorders (ASD). In this clinical perspective, authors decently argue this use could be advantageous and multi-folded for this population.PMID:38076666 | PMC:PMC10698851

Source: Psychopharmacology Bulletin - December 11, 2023 Category: Psychiatry & Psychology Authors: Ahmed Naguy Seshni Gourika Moodliar-Rensburg Bibi Alamiri Source Type: research